14th Annual Sickle Cell Disease Research and Educational Symposium and 43rd National Sickle Cell Disease Scientific Meeting

Wednesday, September 23rd

Welcome Remarks, Summit Introduction and Charge

Plenary Session Theme 1: Navigating the Emerging Complexity of Reimbursement for Sickle Cell Disease Care

Plenary Session Theme 2: Addressing the Dearth in Sickle Cell Disease Provider Care

Patient Symposium

No Money, No Mission: State and Other Health Care Financing Innovations for Sickle Cell Disease Care

Keynote Speaker Yolanda Cash Jackson

Investigational New Drug, Device and Therapeutics Symposium

Genetics and Genomics Research Educational Session

Thursday, September 24th

Pharmacologic, Nutraceutical and Pharmaceutical Trials Educational Session

Endocrine Dysfunction Plenary Session

Genetics and Genomics Research Educational Session

Patient and Caregiver Epidemiology Educational Session

Pain and Palliative Care Research and Cannabis Educational Session

Adult Sickle Cell Care Delivery Programs Perils and Progress Educational Session

Surgery in Sickle Cell Disease Educational Session

Provider Epidemiology, Training and Supply Improvement Educational Session

Ideas and Incubators Meet Investors Session

Mechanisms of Sickling and Vasculopathy Educational Session

Behavioral Science Symposium Educational Session

ASH SCD Clinical Practice Guidelines 2020 Report Educational Session

Allied Health, Nursing, Case Management Educational Session

The State of Sickle Cell

Keynote Speaker Vence Bonham

Friday, September 25th

Abstract Breakout Session II Clinical Research Oral Presentations

Abstract Breakout Session I Psychosocial Oral Presentations

Abstract Breakout Session I Health Services Oral Presentations

Abstract Breakout Session I Basic Science Oral Presentation

The Global Symposium

Scientific Keynote Speaker Griffin P Rodgers

SC Trait and VTE (+ COVID)

No Money, No Mission: State and Other Health Care Financing Innovations for Sickle Cell Disease Care

You are unauthorized to view this page.